Coherus Biosciences | Ventes





Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Akebia Therapeutics USD 57.34M 10.84M 2025-03
ALKERMES USD 394.2M 3.5M 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amarin USD 49.67M 23.07M 2025-09
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.84B 30M 2025-09
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 7.6M 46.54M 2025-03
Eli Lilly USD 19.3B 1.7B 2025-12
Fujifilm JPY 857.35B 34.47B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Ironwood Pharmaceuticals USD 122.06M 36.82M 2025-09
Merck USD 16.4B 880M 2025-12
Myriad Genetics USD 205.7M 7.4M 2025-09
Pacira USD 179.52M 1.58M 2025-09
Perrigo USD 1.04B 16.3M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Vertex Pharmaceuticals USD 3.08B 120M 2025-09
Xencor USD 21M 22.61M 2025-09
Zoetis USD 2.4B 60M 2025-09


Coherus Biosciences Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.